文献速递肝病消化道肿瘤与早癌

非酒精性脂肪性肝病流行模型显示疾病负担呈指数级增长

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.
PubMed 文献 · Hepatology · 2017-12-01

该研究采用马尔可夫模型预测美国非酒精性脂肪性肝病(NAFLD)的疾病进展。预计2015至2030年,NAFLD患病病例将增加21%,非酒精性脂肪性肝炎(NASH)病例增加63%,失代偿期肝硬化、肝细胞癌(HCC)和肝病死亡分别增加168%、137%和178%。结论认为,随着成人肥胖和2型糖尿病持续高发及人口老龄化,NAFLD相关肝病和死亡率将上升。

要点

  • 2030年失代偿期肝硬化、HCC和肝病死亡将分别增至105430例、12240例和78300例。

核心结论

  • 随着成人肥胖和糖尿病持续高发及人口老龄化,美国NAFLD相关肝病和死亡率将增加。
  • 需要采取策略减缓NAFLD病例增长,并需要治疗选择以减轻疾病负担。

研究设计与样本

  • 采用马尔可夫模型预测NAFLD疾病进展。
  • NAFLD发病率基于成人肥胖和2型糖尿病患病率的历史及预测变化。
  • 假设来自已发表文献,并用国家监测数据对NAFLD相关HCC发病率进行验证。
  • 量化预测至2030年NAFLD相关肝硬化、晚期肝病和肝病死亡的变化。

主要发现

  • 2030年成人(≥15岁)NAFLD总体患病率预计为33.5%,NAFLD人群中位年龄从50岁增至55岁。
  • 2015年约20%的NAFLD病例为NASH,2030年升至27%。
  • 失代偿期肝硬化发病率增加168%至2030年105430例,HCC发病率增加137%至12240例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH) are highly prevalent in the United States, where they are a growing cause of cirrhosis and hepatocellular carcinoma (HCC) and increasingly an indicator for liver transplantation. A Markov model was used to forecast NAFLD disease progression. Incidence of NAFLD was based on historical and projected changes in adult prevalence of obesity and type 2 diabetes mellitus (DM). Assumptions were derived from published literature where available and validated using national surveillance data for incidence of NAFLD-related HCC. Projected changes in NAFLD-related cirrhosis, advanced liver disease, and liver-related mortality were quantified through 2030. Prevalent NAFLD cases are forecasted to increase 21%, from 83.1 million (2015) to 100.9 million (2030), while prevalent NASH cases will increase 63% from 16.52 million to 27.00 million cases. Overall NAFLD prevalence among the adult population (aged ≥15 years) is projected at 33.5% in 2030, and the median age of the NAFLD population will increase from 50 to 55 years during 2015-2030. In 2015, approximately 20% of NAFLD cases were classified as NASH, increasing to 27% by 2030, a reflection of both disease progression and an aging population. Incidence of decompensated cirrhosis will increase 168% to 105,430 cases by 2030, while incidence of HCC will increase by 137% to 12,240 cases. Liver deaths will increase 178% to an estimated 78,300 deaths in 2030. During 2015-2030, there are projected to be nearly 800,000 excess liver deaths. CONCLUSION: With continued high rates of adult obesity and DM along with an aging population, NAFLD-related liver disease and mortality will increase in the United States. Strategies to slow the growth of NAFLD cases and therapeutic options are necessary to mitigate disease burden. (Hepatology 2018;67:123-133).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Estes C, Razavi H, Loomba R, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2017. PMID: 28802062. doi:10.1002/hep.29466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。